VACCINE AND RNA THERAPEUTICS
Vaccines and RNA and genomic-based therapies have gained a lot of attention recently due to COVID-19. Last year was a breakthrough for the technology with the approval of the first mRNA-based therapy. The Vaccine and RNA Therapeutics stream will explore
the technical challenges facing the formulation, development, manufacturing, and supply of next-generation vaccines, mRNA vaccines, mRNA gene therapies, RNAi, gene therapies, and cell therapies. Experts from pharma, biotech, academia, and government
labs will convene in Boston in person and virtually to deep dive into the challenges associated with successfully developing and delivering these next-generation therapeutics.